Papers
1
Total Citations
21
H-Index
1
About
Dr. Marc Nash is a leading figure in radiation oncology, with a focused expertise in stereotactic body radiation therapy (SBRT) for prostate cancer. His most impactful work addresses a critical challenge in the field: the lack of objective standards for treatment plan quality. In his landmark 2013 study, "Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with CyberKnife," Dr. Nash pioneered a systematic approach to dose constraint standardization. This work, cited over 20 times, directly tackled the variability inherent in physician-dependent planning, providing a reproducible framework that significantly enhanced both plan consistency and the protection of organs at risk. By replacing subjective judgment with objective criteria, Dr. Nash’s contributions have helped elevate the standard of care in prostate SBRT, ensuring that patients receive more reliable, high-quality treatments. His research remains a cornerstone for clinicians seeking to optimize therapeutic outcomes while minimizing toxicity, cementing his reputation as a key innovator in modern radiation therapy.
Research Focus
Key Achievements
Top Papers
- 1